Molina Healthcare(US:MOH) Globenewswireยท2025-10-16 16:57Core Viewpoint - Molina Healthcare, Inc. is facing significant financial challenges, leading to a class action lawsuit for investors who purchased securities during a specified period due to misleading information regarding earnings guidance and medical cost pressures [1][3]. Financial Performance - On July 7, 2025, Molina reported second quarter adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [3]. - The company cut its full-year 2025 adjusted earnings per share guidance by 10.2% at the midpoint, revising it from at least $24.50 per share to a range of $21.50 to $22.50 per share [3]. - Molina's stock price fell by $6.97 per share, or 2.9%, closing at $232.61 per share on July 7, 2025, following the earnings announcement [3]. Subsequent Developments - On July 23, 2025, Molina further reduced its full-year 2025 earnings guidance, now expecting adjusted earnings to be no less than $19.00 per diluted share, representing a 13.6% cut from the previous guidance [3]. - The company's GAAP net income for the second quarter was reported at $4.75 per diluted share, an 8% decrease year over year [3]. - Molina's stock price experienced a significant drop of $32.03 per share, or 16.84%, closing at $158.22 per share on July 24, 2025, after the second guidance cut [3]. Legal Actions - The Portnoy Law Firm is advising Molina investors about a class action lawsuit for those who bought securities between February 5, 2025, and July 23, 2025, with a deadline to file a lead plaintiff motion by December 2, 2025 [1][2].